Genes and pathways differentially expressed in the brains of Fxr2 knockout mice

Neurobiology of Disease

Volumn 32, Issue 3, 2008, Pages 510-520

  Cavallaro, Sebastiano ^a   Paratore, Sabrina ^a   Fradale, Francesco ^a   de Vrij, Femke M S ^b   Willemsen, Rob ^b   Oostra, Ben A ^b  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fragile X syndrome; FXR1; FXR2; Genomics; Knockout; Mental retardation; Microarray

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; FRAGILE X SYNDROME; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; MALE; MENTAL DEFICIENCY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BRAIN; CEREBELLUM; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, AMPA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 56349138601     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.09.008     Document Type: Article

References (74)

1. Aoki Y., Niihori T., Kawame H., Kurosawa K., Ohashi H., Tanaka Y., Filocamo M., Kato K., Suzuki Y., Kure S., and Matsubara Y. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet. 37 (2005) 1038-1040
2. Arikawa-Hirasawa E., Wilcox W.R., Le A.H., Silverman N., Govindraj P., Hassell J.R., and Yamada Y. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat. Genet. 27 (2001) 431-434
3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000) 25-29
4. Ashley Jr. C.T., Wilkinson K.D., Reines D., and Warren S.T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262 (1993) 563-566
5. Ashwood P., Wills S., and Van de W.J. The immune response in autism: a new frontier for autism research. J. Leukoc. Biol. 80 (2006) 1-15
6. Bakker C.E., de Diego O.Y., Bontekoe C., Raghoe P., Luteijn T., Hoogeveen A.T., Oostra B.A., and Willemsen R. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp. Cell Res. 258 (2000) 162-170
7. Bontekoe C.J., McIlwain K.L., Nieuwenhuizen I.M., Yuva-Paylor L.A., Nellis A., Willemsen R., Fang Z., Kirkpatrick L., Bakker C.E., McAninch R., Cheng N.C., Merriweather M., Hoogeveen A.T., Nelson D., Paylor R., and Oostra B.A. Knockout mouse model for Fxr2: a model for mental retardation. Hum. Mol. Genet. 11 (2002) 487-498
8. Brilliant M.H., King R., Francke U., Schuffenhauer S., Meitinger T., Gardner J.M., Durham-Pierre D., and Nakatsu Y. The mouse pink-eyed dilution gene: association with hypopigmentation in Prader-Willi and Angelman syndromes and with human OCA2. Pigment Cell Res. 7 (1994) 398-402
9. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., and Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107 (2001) 477-487
10. Cavallaro S., D'Agata V., Manickam P., Dufour F., and Alkon D.L. Memory-specific temporal profiles of gene expression in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16279-16284
11. Coy J.F., Sedlacek Z., Bachner D., Hameister H., Joos S., Lichter P., Delius H., and Poustka A. Highly conserved 3′ UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1. Hum. Mol. Genet. 4 (1995) 2209-2218
12. Cruz-Aguado R., Almaguer-Melian W., Diaz C.M., Lorigados L., and Bergado J. Behavioral and biochemical effects of glutathione depletion in the rat brain. Brain Res. Bull. 55 (2001) 327-333
13. D'Agata V., Warren S., Zhao W., Torre E., Alkon D., and Cavallaro S. Gene expression profiles in a transgenic animal model of fragile x syndrome. Neurobiol. Dis. 10 (2002) 211
14. Di Cunto F., Imarisio S., Hirsch E., Broccoli V., Bulfone A., Migheli A., Atzori C., Turco E., Triolo R., Dotto G.P., Silengo L., and Altruda F. Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. Neuron 28 (2000) 115-127
15. Doniger S.W., Salomonis N., Dahlquist K.D., Vranizan K., Lawlor S.C., and Conklin B.R. MAPPFinder: using gene ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome. Biol. 4 (2003) R7
16. Ekker S.C., Ungar A.R., Greenstein P., von Kessler D.P., Porter J.A., Moon R.T., and Beachy P.A. Patterning activities of vertebrate hedgehog proteins in the developing eye and brain. Curr. Biol. 5 (1995) 944-955
17. Ericson J., Muhr J., Placzek M., Lints T., Jessell T.M., and Edlund T. Sonic hedgehog induces the differentiation of ventral forebrain neurons: a common signal for ventral patterning within the neural tube. Cell 81 (1995) 747-756
18. Fisch G.S., Carpenter N., Holden J.J., Howard-Peebles P.N., Maddalena A., Borghgraef M., Steyaert J., and Fryns J.P. Longitudinal changes in cognitive and adaptive behavior in fragile X females: a prospective multicenter analysis. Am. J. Med. Genet. 83 (1999) 308-312
19. Fisch G.S., Simensen R., Tarleton J., Chalifoux M., Holden J.J., Carpenter N., Howard-Peebles P.N., and Maddalena A. Longitudinal study of cognitive abilities and adaptive behavior levels in fragile X males: a prospective multicenter analysis. Am. J. Med. Genet. 64 (1996) 356-361
20. Forti E., Aksanov O., and Birk R.Z. Temporal expression pattern of Bardet-Biedl syndrome genes in adipogenesis. Int. J. Biochem. Cell Biol. 39 (2007) 1055-1062
21. Freund L.S., and Reiss A.L. Cognitive profiles associated with the fra(X) syndrome in males and females. Am. J. Med. Genet. 38 (1991) 542-547
22. Fu Y.H., Kuhl D.P., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., Verkerk A.J., Holden J.J., Fenwick Jr. R.G., and Warren S.T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67 (1991) 1047-1058
23. Fukui K., Onodera K., Shinkai T., Suzuki S., and Urano S. Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems. Ann. N. Y. Acad. Sci. 928 (2001) 168-175
24. Garnon J., Lachance C., Di Marco S., Hel Z., Marion D., Ruiz M.C., Newkirk M.M., Khandjian E.W., and Radzioch D. Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. J. Biol. Chem. 280 (2005) 5750-5763
25. Guazzi G.C., Martin J.J., Philippart M., Roels H., Hooft C., Van der E.H., Delbeke M.J., and Vrints L. Wolman's disease. Distribution and significance of the central nervous system lesions. Pathol. Eur. 3 (1968) 266-277
26. Hehr U., Gross C., Diebold U., Wahl D., Beudt U., Heidemann P., Hehr A., and Mueller D. Wide phenotypic variability in families with holoprosencephaly and a sonic hedgehog mutation. Eur. J. Pediatr. 163 (2004) 347-352
27. Hellsten E., Vesa J., Jalanko A., and Peltonen L. From locus to cellular disturbances: positional cloning of the infantile neuronal ceroid lipofuscinosis gene. Neuropediatrics 28 (1997) 9-11
28. Hynes M., Porter J.A., Chiang C., Chang D., Tessier-Lavigne M., Beachy P.A., and Rosenthal A. Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron 15 (1995) 35-44
29. Iozzo R.V. Perlecan: a gem of a proteoglycan. Matrix Biol. 14 (1994) 203-208
30. Iozzo R.V., Cohen I.R., Grassel S., and Murdoch A.D. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302 Pt 3 (1994) 625-639
31. Jensen B.S., Hertz M., Christophersen P., and Madsen L.S. The Ca2+-activated K+ channel of intermediate conductance: a possible target for immune suppression. Expert. Opin. Ther. Targets. 6 (2002) 623-636
32. Kishino T., Lalande M., and Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15 (1997) 70-73
33. Kloting N., Wilke B., and Kloting I. Triplet repeat in the Repin1 3′-untranslated region on rat chromosome 4 correlates with facets of the metabolic syndrome. Diabetes Metab Res. Rev. 23 (2007) 406-410
34. Koch G., Lalley P.A., McAvoy M., and Shows T.B. Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19. Somatic. Cell Genet. 7 (1981) 345-358
35. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., and Volpe B.T. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
36. Lee H.K., Takamiya K., Han J.S., Man H., Kim C.H., Rumbaugh G., Yu S., Ding L., He C., Petralia R.S., Wenthold R.J., Gallagher M., and Huganir R.L. Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112 (2003) 631-643
37. Lee S.T., Nicholls R.D., Jong M.T., Fukai K., and Spritz R.A. Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics 26 (1995) 354-363 %20
38. Li J., Pelletier M.R., Perez Velazquez J.L., and Carlen P.L. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol. Cell Neurosci. 19 (2002) 138-151
39. Lipshutz R.J., Fodor S.P., Gingeras T.R., and Lockhart D.J. High density synthetic oligonucleotide arrays. Nat. Genet. 21 (1999) 20-24
40. Lugtenberg D., Yntema H.G., Banning M.J., Oudakker A.R., Firth H.V., Willatt L., Raynaud M., Kleefstra T., Fryns J.P., Ropers H.H., Chelly J., Moraine C., Gecz J., van Reeuwijk J., Nabuurs S.B., de Vries B.B., Hamel B.C., de Brouwer A.P., and van Bokhoven H. ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. Am. J. Hum. Genet. 78 (2006) 265-278
41. Lutz R.E. Trinucleotide repeat disorders. Semin. Pediatr. Neurol. 14 (2007) 26-33
42. Makedonski K., Abuhatzira L., Kaufman Y., Razin A., and Shemer R. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet. 14 (2005) 1049-1058
43. Mauler F., Hinz V., Horvath E., Schuhmacher J., Hofmann H.A., Wirtz S., Hahn M.G., and Urbahns K. Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma. Eur. J. Neurosci. 20 (2004) 1761-1768
44. Murata K., Nose M., Ndhlovu L.C., Sato T., Sugamura K., and Ishii N. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases. J. Immunol. 169 (2002) 4628-4636
45. Napoli C., and Palinski W. Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis. Neurobiol. Aging 26 (2005) 293-302
46. Nicholls R.D., Gottlieb W., Russell L.B., Davda M., Horsthemke B., and Rinchik E.M. Evaluation of potential models for imprinted and nonimprinted components of human chromosome 15q11-q13 syndromes by fine-structure homology mapping in the mouse. Proc. Natl. Acad. Sci U. S. A. 90 (1993) 2050-2054
47. Nicole S., Davoine C.S., Topaloglu H., Cattolico L., Barral D., Beighton P., Hamida C.B., Hammouda H., Cruaud C., White P.S., Samson D., Urtizberea J.A., Lehmann-Horn F., Weissenbach J., Hentati F., and Fontaine B. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat. Genet. 26 (2000) 480-483
48. Paradis C.M., Gironda F., and Bennett M. Cognitive impairment in Schwartz-Jampel syndrome: a case study. Brain Lang 56 (1997) 301-305
49. Parmantier E., Lynn B., Lawson D., Turmaine M., Namini S.S., Chakrabarti L., McMahon A.P., Jessen K.R., and Mirsky R. Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron 23 (1999) 713-724
50. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. Fourth Edition (1998)
51. Restivo L., Ferrari F., Passino E., Sgobio C., Bock J., Oostra B.A., Bagni C., and Ammassari-Teule M. Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc. Natl. Acad. Sci U. S. A. 102 (2005) 11557-11562
52. Roelink H., Augsburger A., Heemskerk J., Korzh V., Norlin S., Altaba A., Tanabe Y., Placzek M., Edlund T., and Jessell T.M. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell 76 (1994) 761-775
53. Salomonis N., Cotte N., Zambon A.C., Pollard K.S., Vranizan K., Doniger S.W., Dolganov G., and Conklin B.R. Identifying genetic networks underlying myometrial transition to labor. Genome Biol. 6 (2005) R12
54. Shoichet S.A., Hoffmann K., Menzel C., Trautmann U., Moser B., Hoeltzenbein M., Echenne B., Partington M., van Bokhoven H., Moraine C., Fryns J.P., Chelly J., Rott H.D., Ropers H.H., and Kalscheuer V.M. Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. Am. J. Hum. Genet. 73 (2003) 1341-1354
55. Siomi H., Siomi M.C., Nussbaum R.L., and Dreyfuss G. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74 (1993) 291-298
56. Siomi M.C., Siomi H., Sauer W.H., Srinivasan S., Nussbaum R.L., and Dreyfuss G. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14 (1995) 2401-2408
57. Snow A.D., Mar H., Nochlin D., Sekiguchi R.T., Kimata K., Koike Y., and Wight T.N. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137 (1990) 1253-1270
58. Snow A.D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W.A., and Morgan D.G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 12 (1994) 219-234
59. Spencer C.M., Serysheva E., Yuva-Paylor L.A., Oostra B.A., Nelson D.L., and Paylor R. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Hum. Mol. Genet. 15 (2006) 1984-1994
60. Staleva L., Manga P., and Orlow S.J. Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism. Mol. Biol. Cell. 13 (2002) 4206-4220
61. Tamanini F., Meijer N., Verheij C., Willems P.J., Galjaard H., Oostra B.A., and Hoogeveen A.T. FMRP is associated to the ribosomes via RNA. Hum. Mol. Genet. 5 (1996) 809-813
62. Tassabehji M. Williams-Beuren syndrome: a challenge for genotype-phenotype correlations. Hum. Mol. Genet. 12 Spec No 2 (2003) R229-R237
63. The Dutch-Belgian Fragile X Consortium. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78 (1994) 23-33
64. Tian Q., Stepaniants S.B., Mao M., Weng L., Feetham M.C., Doyle M.J., Yi E.C., Dai H., Thorsson V., Eng J., Goodlett D., Berger J.P., Gunter B., Linseley P.S., Stoughton R.B., Aebersold R., Collins S.J., Hanlon W.A., and Hood L.E. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol. Cell Proteomics. 3 (2004) 960-969
65. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5116-5121
66. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57 (2005) 67-81
67. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., and Zhang F.P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 (1991) 905-914
68. Wang X., Ria M., Kelmenson P.M., Eriksson P., Higgins D.C., Samnegard A., Petros C., Rollins J., Bennet A.M., Wiman B., de Faire U., Wennberg C., Olsson P.G., Ishii N., Sugamura K., Hamsten A., Forsman-Semb K., Lagercrantz J., and Paigen B. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat. Genet. 37 (2005) 365-372
69. Weeber E.J., and Sweatt J.D. Molecular neurobiology of human cognition. Neuron 33 (2002) 845-848
70. Yang M., and Mattes J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol. Ther. 117 (2008) 94-104
71. Yao H.H., Whoriskey W., and Capel B. Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev. 16 (2002) 1433-1440
72. Zambon A.C., McDearmon E.L., Salomonis N., Vranizan K.M., Johansen K.L., Adey D., Takahashi J.S., Schambelan M., and Conklin B.R. Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 4 (2003) R61
73. Zhang Y., O'Connor J.P., Siomi M.C., Srinivasan S., Dutra A., Nussbaum R.L., and Dreyfuss G. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 14 (1995) 5358-5366
74. Zhao W., Meiri N., Xu H., Cavallaro S., Quattrone A., Zhang L., and Alkon D.L. Spatial learning induced changes in expression of the ryanodine type II receptor in the rat hippocampus. FASEB J. 14 (2000) 290-300